Literature DB >> 11779860

Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2.

Laura A Maile1, David R Clemmons.   

Abstract

Activation of insulin-like growth factor I receptor (IGF-IR) kinase is an important site of control of IGF-I-linked intracellular signaling pathways. One potentially important regulatory variable is IGF-IR dephosphorylation. It has been shown that SHP-2, a tyrosine phosphatase, can bind to the activated IGF-IR in vitro; however, its role in IGF-IR dephosphorylation in whole cells is unknown. These studies were undertaken to determine whether SHP-2 was a candidate for mediating IGF-IR dephosphorylation. The IGF-IR in smooth muscle cells was dephosphorylated rapidly beginning 10 min after ligand addition, and this was temporally associated with SHP-2 binding to the receptor. IGF-I stimulated SHPS-1 phosphorylation and the subsequent recruitment of SHP-2. In cells expressing a SHPS-1 mutant that did not bind SHP-2 there was no recruitment of SHP-2 to the IGF-IR. Cells expressing a catalytically inactive form of SHP-2 showed SHP-2 recruitment to SHPS-1, but this did not result in SHPS-1 dephosphorylation, and there was a prolonged IGF-IR phosphorylation response after IGF-I stimulation. These studies indicate that IGF-IR stimulates phosphorylation of SHPS-1 which is critical for SHP-2 recruitment to the plasma membrane and for its recruitment to the IGF-IR. Recruitment of SHP-2 to the receptor then results in receptor dephosphorylation. The regulation of this process may be an important determinant of IGF-IR-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779860     DOI: 10.1074/jbc.M109258200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  You can't go home again: transcriptionally driven alteration of cell signaling by NGF.

Authors:  Lloyd A Greene; James M Angelastro
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 2.  Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.

Authors:  David R Clemmons; Laura A Maile; Yan Ling; J Yarber; Walker H Busby
Journal:  Growth Horm IGF Res       Date:  2007-04-06       Impact factor: 2.372

3.  Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation.

Authors:  Gang Xi; Christine Wai; Morris F White; David R Clemmons
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

4.  The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.

Authors:  Laura A Maile; Jane Badley-Clarke; David R Clemmons
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

5.  Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

6.  Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.

Authors:  Kristopher C Carver; Timothy M Piazza; Linda A Schuler
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

7.  Identification of compounds that inhibit IGF-I signaling in hyperglycemia.

Authors:  Laura A Maile; Lee B Allen; Umadevi Veluvolu; Byron E Capps; Walker H Busby; Michael Rowland; David R Clemmons
Journal:  Exp Diabetes Res       Date:  2010-01-06

8.  Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Authors:  Laura A Maile; Byron E Capps; Emily C Miller; Lee B Allen; Umadevi Veluvolu; Ariel W Aday; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-02-21

9.  Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.

Authors:  Alan C Rapraeger; Brian J Ell; Madhuchhanda Roy; Xuehui Li; Orrianne R Morrison; Grant M Thomas; DeannaLee M Beauvais
Journal:  FEBS J       Date:  2013-02-11       Impact factor: 5.542

Review 10.  Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis.

Authors:  Alan C Rapraeger
Journal:  FEBS J       Date:  2013-02-24       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.